MoneyWorks4Me

Clarification sought from Dr Reddys Laboratories

01 Sep 2017 Evaluate

The Exchange has sought clarification from Dr Reddys Laboratories on September 01, 2017 with reference to news flashed on http://www.thehindubusinessline.com dated September 01, 2017 quoting ‘Dr Reddys settles patent row with Vivus’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..